Product

LP-001

Aliases

LP-001 Dose 1 (Single), LP-001 Dose 2 (Single), LP-001 Dose 3 (Single), LP-001 Dose 4 (Single), LP-001 Dose 5 (Single) (3 other aliases)

1 clinical trial

1 indication

Indication

Myelodysplastic Syndrome

Clinical trial

A Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetics of LP-001 Injection in Healthy Subjects Following Single and Multiple Doses

Status: Active (not recruiting), Estimated PCD: 2024-01-02